Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study.
Jouego CG, Gils T, Piubello A, Mbassa V, Kuate A, Ngono A, Belinga E, Etoundi A, Tollo A, Makondi D, André E, Masumbe P, Lynen L, Noeske J, Decroo T. Jouego CG, et al. Among authors: decroo t. Int J Infect Dis. 2022 Nov;124:81-88. doi: 10.1016/j.ijid.2022.09.012. Epub 2022 Sep 13. Int J Infect Dis. 2022. PMID: 36108960 Free article.
Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study.
Mesic A, Khan WH, Lenglet A, Lynen L, Ishaq S, Phyu EHH, Mar HT, Oraegbu A, Seddiq MK, Amirzada HK, Fernhout J, Kamau C, Ariti C, Gomez D, Decroo T. Mesic A, et al. Among authors: decroo t. PLoS One. 2020 Aug 21;15(8):e0237787. doi: 10.1371/journal.pone.0237787. eCollection 2020. PLoS One. 2020. PMID: 32822375 Free PMC article.
Person-centred care and short oral treatment for rifampicin-resistant tuberculosis improve retention in care in Kandahar, Afghanistan.
Mesic A, Ishaq S, Khan WH, Mureed A, Mar HT, Khaing EE, Bermudez-Aza E, Rose L, Lynen L, Seddiq MK, Amirzada HK, Keus K, Decroo T. Mesic A, et al. Among authors: decroo t. Trop Med Int Health. 2022 Feb;27(2):207-215. doi: 10.1111/tmi.13716. Epub 2022 Jan 17. Trop Med Int Health. 2022. PMID: 34978748 Free PMC article. Clinical Trial.
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda.
Ngabonziza JS, Habimana YM, Decroo T, Migambi P, Dushime A, Mazarati JB, Rigouts L, Affolabi D, Ivan E, Meehan CJ, Van Deun A, Fissette K, Habiyambere I, Nyaruhirira AU, Turate I, Semahore JM, Ndjeka N, Muvunyi CM, Condo JU, Gasana M, Hasker E, Torrea G, de Jong BC. Ngabonziza JS, et al. Among authors: decroo t. Int J Tuberc Lung Dis. 2020 Mar 1;24(3):329-339. doi: 10.5588/ijtld.19.0298. Int J Tuberc Lung Dis. 2020. PMID: 32228764
The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance.
Van Deun A, Decroo T, Kya Jai Maug A, Hossain MA, Gumusboga M, Mulders W, Ortuño-Gutiérrez N, Lynen L, de Jong BC, Rieder HL. Van Deun A, et al. Among authors: decroo t. PLoS One. 2020 May 18;15(5):e0233500. doi: 10.1371/journal.pone.0233500. eCollection 2020. PLoS One. 2020. PMID: 32421749 Free PMC article.
135 results